ArticleJournal of virology2026
Genotype IX Newcastle disease virus isolated from wild birds is attenuated by hemagglutinin-neuraminidase mutation.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Newcastle disease virus (NDV) infects a wide range of hosts, including poultry and wild birds. However, most research has focused on poultry-derived strains, with limited studies on the biological characteristics of NDV isolated from wild birds. This study investigated genotype IX NDV strains from wild birds. Genetic evolution and viral ecology analyses suggest possible poultry-to-wild-bird transmission of this genotype. Most of the genotype IX NDV strains, isolated from asymptomatic wild birds, were highly pathogenic in chickens, but one strain isolated from spotted dove exhibited attenuated virulence. This dove-derived strain showed the highest homology with a virulent strain from Eurasian blackbird, differing by only 12 amino acids across proteins. Using reverse genetics, we identified the viral HN protein as a critical determinant of virulence in the dove strain. The coexistence of F110 and G116 residues in the HN protein was associated with reduced HN cell-surface abundance and downstream decreases in viral membrane fusion activity, replication capacity, and tissue tropism. Computational modeling further suggests that the F110/G116 combination may be linked to a local α-helix within the HN head-stalk linker region, providing a plausible structural context for these effects. Crucially, this dove strain's fusion protein retained the furin-cleavable, virulent-type "¹¹²RRQRRF¹¹⁷" cleavage site. Immunizing chickens with this strain induced high antibody titers within 1 week, and titers persisted at high levels for 13 weeks and provided complete protection against virulent challenge at both early and late post-immunization time points. Our findings uncover an HN-linked attenuation mechanism centered on residues 110 and 116, primarily through their effects on HN cell-surface abundance and downstream fusion activity, offering new insights into the development of immunogenic NDV vaccines with reduced virulence.IMPORTANCEWild birds, as natural reservoirs of Newcastle disease virus (NDV), harbor a diverse range of viral strains. However, research on these strains remains limited. Here, we show that genotype IX NDV detected in wild birds most likely reflects possible poultry-to-wild bird transmission rather than long-term endemic circulation in wild populations. Using isolates derived from wild birds, we report a novel attenuation mechanism involving structural modification of the HN protein's head-neck linker region. Therefore, research on wild bird-derived isolates not only provides insights into the epidemiological dynamics of NDV transmission but also facilitates the identification of novel attenuated strains, which could aid in the development of high-efficacy NDV vaccines and NDV-based viral vectors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.